P5436 Antibody

Basic Characterization and Applications

• What is P5436 Antibody and what organism is it reactive to?

  P5436 Antibody (product code CSB-PA754149XA01DIL) is a polyclonal antibody raised in rabbits against recombinant Danio rerio (zebrafish) P5436 protein . It specifically reacts with Danio rerio P5436 protein (UniProt number Q6NWH0), which is also known as UPF0696 protein C11orf68 homolog . The antibody has been validated for ELISA and Western Blot applications . It's important to note that there is potential for confusion with sodium propionate, which carries the same product number (P5436) in some catalogs, but represents an entirely different compound used in cell culture studies .

• How should P5436 Antibody be stored and handled to maintain its effectiveness?

  For optimal stability and performance, P5436 Antibody should be stored at either -20°C or -80°C upon receipt . Repeated freeze-thaw cycles should be avoided as they can compromise antibody functionality. The antibody is supplied in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . When handling the antibody for experiments, it's advisable to aliquot the stock solution into smaller volumes before freezing to minimize freeze-thaw cycles and maintain consistent performance across experiments.

• What are the validated applications for P5436 Antibody in zebrafish research?

  P5436 Antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western Blot applications specifically for detecting the target protein in Danio rerio samples . When using this antibody for Western Blot, researchers should follow standard protocols, including appropriate blocking (typically 5% skim milk for 1 hour at room temperature), primary antibody incubation, and secondary antibody detection systems as demonstrated in comparable immunodetection protocols . The antibody is purified using antigen affinity methods, which generally provides higher specificity for the target protein .

Experimental Design and Methodology

• How can researchers verify the specificity of P5436 Antibody in their experimental systems?

  To verify specificity, researchers should implement multiple validation approaches:

  1. Positive and negative controls: Use the provided 200μg antigens as positive control and the 1ml pre-immune serum as negative control that come with the antibody .

  2. Knockdown/knockout validation: If possible, compare antibody reactivity in wild-type samples versus those where the target protein has been depleted through genetic approaches.

  3. Cross-reactivity testing: Test the antibody against related proteins or in non-zebrafish samples to confirm specificity.

  4. Peptide competition assay: Pre-incubate the antibody with excess target peptide to confirm signal suppression in subsequent detection assays.

  This multi-pronged approach helps address the reproducibility crisis in biomedical research that has been partly attributed to poor conduct of commercial antibodies .

• What is the recommended protocol for using P5436 Antibody in Western blot analysis?

  Based on comparable immunodetection protocols from the search results, the following methodology is recommended:

  1. Sample preparation: Lyse cells/tissues in cold lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, 1 mM Na₃VO₄, 1 mM NaF, and 1× protease inhibitor cocktail) .

  2. Protein separation: Load 10-15 μg protein samples on 4-20% precast gels.

  3. Transfer: Transfer proteins to nitrocellulose membranes.

  4. Blocking: Block membranes with 5% skim milk in TBST for 1 hour at room temperature.

  5. Primary antibody: Incubate with P5436 Antibody at 1:1000 dilution overnight at 4°C.

  6. Secondary antibody: Incubate with anti-rabbit secondary antibody (1:5000) for 1 hour at room temperature.

  7. Detection: Visualize using ECL solution and appropriate imaging system.

  This protocol follows standard procedures used for antibody detection in similar experimental contexts .

• How should researchers address potential batch-to-batch variability with P5436 Antibody?

  To mitigate the impact of batch variability:

  1. Record lot numbers: Document the specific lot number used in each experiment.

  2. Initial validation: When receiving a new batch, perform side-by-side comparisons with previous lots using the same samples and protocols.

  3. Standardization: Use internal controls and standardized protocols consistently across experiments.

  4. Two-tier approach: As suggested in the literature, implement a two-tier approach that enables scientists to anticipate how an antibody is likely to perform when repeated purchases are required .

  5. Preserve reference samples: Maintain a collection of reference samples with known reactivity patterns to validate new antibody batches.

  This systematic approach helps ensure research reproducibility despite potential manufacturing variations.

Advanced Research Applications

• How can P5436 Antibody be utilized in studying protein degradation pathways?

  For investigating protein degradation pathways:

  1. Proteasomal degradation studies: Similar to methodologies used in studies of EHMT2 , researchers can use P5436 Antibody in conjunction with proteasome inhibitors like MG132 to determine if the target protein undergoes proteasomal degradation.

  2. Cycloheximide chase assays: Combine antibody detection with cycloheximide treatment to monitor protein half-life and degradation kinetics, following protocols similar to those used in the study of EHMT2 degradation .

  3. Ubiquitination detection: Use the antibody in immunoprecipitation experiments followed by ubiquitin detection to assess if the target protein undergoes ubiquitin-mediated degradation, similar to the co-immunoprecipitation protocols described for FLAG-tagged proteins .

  4. Phosphorylation state analysis: Combine with phospho-specific antibodies to determine if degradation is regulated by phosphorylation events.

  These approaches can provide insights into regulatory mechanisms controlling protein turnover.

• What considerations should be made when designing immunoprecipitation experiments with P5436 Antibody?

  For successful immunoprecipitation:

  1. Buffer optimization: Use a lysis buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, and protease/phosphatase inhibitors .

  2. Antibody coupling: Consider pre-coupling the antibody to protein A/G beads to reduce background from antibody heavy and light chains.

  3. Pre-clearing: Pre-clear lysates with protein A/G beads alone to reduce non-specific binding.

  4. Controls: Include IgG isotype controls and input samples to validate specificity.

  5. Elution conditions: Optimize elution conditions based on intended downstream applications (denaturing vs. native).

  6. Validation: Confirm successful immunoprecipitation by Western blot analysis using a portion of the immunoprecipitated material.

  Following these considerations will help ensure specific and efficient immunoprecipitation of the target protein.

• How might P5436 Antibody be employed in studying protein-protein interactions?

  For investigating protein interactions:

  1. Co-immunoprecipitation: Use P5436 Antibody to pull down the target protein and identify interacting partners by mass spectrometry or Western blot.

  2. Proximity ligation assay (PLA): Combine P5436 Antibody with antibodies against suspected interacting proteins to visualize protein interactions in situ using PLA technology.

  3. Pull-down validations: Validate interactions identified through other methods (e.g., yeast two-hybrid) using antibody-based pull-downs.

  4. Interaction domain mapping: Use P5436 Antibody in combination with domain deletion constructs to map interaction interfaces.

  5. Stimulus-dependent interactions: Assess how different cellular stimuli affect protein interactions using the antibody in time-course or dose-response studies.

  These approaches can help elucidate the protein interaction network of the target protein.

Troubleshooting and Advanced Analysis

• What are common troubleshooting strategies for weak or non-specific signals when using P5436 Antibody?

  When encountering signal issues:

  Problem	Potential Causes	Solutions
  Weak signal	Insufficient antibody concentration	Increase primary antibody concentration or incubation time
  	Low target protein expression	Increase protein loading; use enrichment strategies
  	Inadequate transfer	Optimize transfer conditions for protein size
  	Degraded antibody	Use fresh aliquot; check storage conditions
  High background	Insufficient blocking	Increase blocking time or concentration
  	Too high antibody concentration	Dilute primary and/or secondary antibodies
  	Cross-reactivity	Use more stringent washing; try different blocking agent
  Non-specific bands	Cross-reactivity with related proteins	Use peptide competition assay to identify specific bands
  	Degraded target protein	Add protease inhibitors; fresh sample preparation

  Implementing these troubleshooting strategies systematically can help optimize experimental conditions.

• How can P5436 Antibody be integrated into studies of cellular stress and apoptosis pathways?

  For stress and apoptosis research:

  1. Combination with apoptosis markers: Use P5436 Antibody in conjunction with antibodies against apoptosis markers like cleaved PARP and caspase-3, as demonstrated in studies with sodium propionate .

  2. FACS analysis integration: Combine antibody staining with Annexin V and Dead Cell Assays to correlate target protein expression with apoptotic populations .

  3. Stress-induced protein modification: Monitor changes in protein expression, localization, or post-translational modifications following exposure to various cellular stressors.

  4. Signaling pathway crosstalk: Use phospho-arrays in combination with target protein detection to map pathway interactions, similar to the approach used in studying mTOR signaling .

  5. Time-course studies: Track temporal changes in protein expression during stress response and recovery phases.

  This integrative approach can reveal the target protein's role in cellular stress responses.

• What considerations should be made when using P5436 Antibody for immunohistochemistry in zebrafish tissues?

  For immunohistochemical applications:

  1. Fixation optimization: Test different fixatives (4% paraformaldehyde with 0.2% picric acid has been effective for zebrafish tissues ) and fixation times to preserve both antigenicity and tissue morphology.

  2. Antigen retrieval: Determine whether heat-induced or enzymatic antigen retrieval methods are necessary for optimal staining.

  3. Signal amplification: Consider using signal amplification methods like tyramide signal amplification if target protein expression is low.

  4. Negative controls: Include sections treated with pre-immune serum to assess background staining.

  5. Co-localization studies: Combine with other antibodies (e.g., anti-neuronal nuclear antibody ) to determine spatial relationships with cellular markers.

  6. Whole mount versus sections: Optimize protocols for either whole mount staining or tissue sections depending on experimental goals.

  These methodological considerations will help ensure specific and reproducible immunohistochemical detection.

Cutting-Edge Applications and Future Directions

• How might P5436 Antibody be utilized in developing novel therapeutic approaches?

  Inspired by antibody-based therapeutic strategies:

  1. Target validation: Use the antibody to validate whether the target protein is involved in disease processes, similar to how antibodies targeting TDP-43 were validated for potential ALS and FTD treatments .

  2. Intrabody development: Convert the antibody to single-chain (scFv) format for intracellular expression, following approaches similar to those used for TDP-43-targeting antibodies .

  3. Virus-mediated delivery: Explore virus-mediated delivery systems for antibody or antibody fragments in disease models, as demonstrated with VH7Vk9 antibody .

  4. Modulation of protein function: Assess whether the antibody can modulate protein activity rather than simply detecting it, potentially revealing new therapeutic mechanisms.

  5. Allosteric regulation: Investigate whether the antibody binds to sites that could allosterically regulate protein function, similar to antibodies targeting GCGR .

  These applications leverage antibodies beyond detection tools toward therapeutic development.

• How can computational modeling be integrated with P5436 Antibody studies for enhanced specificity analysis?

  Based on emerging computational approaches:

  1. Binding mode prediction: Apply computational modeling to predict antibody binding modes to the target protein, similar to approaches used in antibody specificity inference .

  2. Epitope mapping: Use computational approaches to identify the likely epitopes recognized by the antibody, facilitating better understanding of specificity.

  3. Cross-reactivity prediction: Apply biophysics-informed models to predict potential cross-reactivity with related proteins .

  4. Specificity optimization: Design modified versions of the antibody with enhanced specificity profiles based on computational predictions .

  5. Integration with experimental data: Combine high-throughput experimental data with computational models to iteratively improve antibody specificity.

  This integration of computational and experimental approaches represents the cutting edge of antibody research and development.

• What emerging technologies could enhance the utility of P5436 Antibody in zebrafish research?

  Future-oriented methodological considerations:

  1. Single-cell antibody-based proteomics: Adapt the antibody for use in emerging single-cell proteomics techniques to analyze target protein expression at the single-cell level.

  2. In vivo antibody imaging: Develop fluorescently labeled versions of the antibody for in vivo imaging in transparent zebrafish embryos.

  3. Proximity-dependent labeling: Combine with techniques like BioID or APEX2 to identify proximal proteins in living cells.

  4. Nanobody conversion: Engineer smaller nanobody versions with improved tissue penetration for in vivo applications.

  5. Correlative microscopy integration: Use the antibody in correlative light and electron microscopy to relate protein localization to ultrastructural features.

  6. CRISPR screening validation: Employ the antibody to validate results from CRISPR screens targeting pathways involving the target protein.

  These emerging approaches could significantly expand the research applications of P5436 Antibody in zebrafish and comparative studies.